Sarcoma GOG 261
March 13, 2013
Location: The Hospital of Central Connecticut
A Randomized Phase III Trial of Paclitaxel plus Carboplatin versus Ifosfamide plus Paclitaxel in Chemotherapy-Naïve Patients with Newly Diagnosed Stage I-IV Persistent or
Recurrent Carcinosarcoma (Mixed Mesodermal Tumors).